227 related articles for article (PubMed ID: 34794045)
21. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
[TBL] [Abstract][Full Text] [Related]
22. Physiological effects of dual target DBS in an individual with Parkinson's disease and a sensing-enabled pulse generator.
Cummins DD; Sandoval-Pistorius SS; Cernera S; Fernandez-Gajardo R; Hammer LH; Starr PA
Parkinsonism Relat Disord; 2024 May; 122():106089. PubMed ID: 38460490
[TBL] [Abstract][Full Text] [Related]
23. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
24. Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson's disease.
Gulberti A; Hamel W; Buhmann C; Boelmans K; Zittel S; Gerloff C; Westphal M; Engel AK; Schneider TR; Moll CK
Clin Neurophysiol; 2015 Mar; 126(3):565-74. PubMed ID: 25085452
[TBL] [Abstract][Full Text] [Related]
25. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
[TBL] [Abstract][Full Text] [Related]
26. Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease.
Tsang EW; Hamani C; Moro E; Mazzella F; Saha U; Lozano AM; Hodaie M; Chuang R; Steeves T; Lim SY; Neagu B; Chen R
Neurology; 2012 Jun; 78(24):1930-8. PubMed ID: 22592373
[TBL] [Abstract][Full Text] [Related]
27. Subthalamic oscillations and phase amplitude coupling are greater in the more affected hemisphere in Parkinson's disease.
Shreve LA; Velisar A; Malekmohammadi M; Koop MM; Trager M; Quinn EJ; Hill BC; Blumenfeld Z; Kilbane C; Mantovani A; Henderson JM; Brontë-Stewart H
Clin Neurophysiol; 2017 Jan; 128(1):128-137. PubMed ID: 27889627
[TBL] [Abstract][Full Text] [Related]
28. Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease.
Yang AI; Vanegas N; Lungu C; Zaghloul KA
J Neurosci; 2014 Sep; 34(38):12816-27. PubMed ID: 25232117
[TBL] [Abstract][Full Text] [Related]
29. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
Ozturk M; Abosch A; Francis D; Wu J; Jimenez-Shahed J; Ince NF
Mov Disord; 2020 Jan; 35(1):91-100. PubMed ID: 31348550
[TBL] [Abstract][Full Text] [Related]
30. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease.
Toledo JB; López-Azcárate J; Garcia-Garcia D; Guridi J; Valencia M; Artieda J; Obeso J; Alegre M; Rodriguez-Oroz M
Neurobiol Dis; 2014 Apr; 64():60-5. PubMed ID: 24361601
[TBL] [Abstract][Full Text] [Related]
31. Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings.
Litvak V; Eusebio A; Jha A; Oostenveld R; Barnes G; Foltynie T; Limousin P; Zrinzo L; Hariz MI; Friston K; Brown P
J Neurosci; 2012 Aug; 32(31):10541-53. PubMed ID: 22855804
[TBL] [Abstract][Full Text] [Related]
32. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease.
Alonso-Frech F; Zamarbide I; Alegre M; Rodríguez-Oroz MC; Guridi J; Manrique M; Valencia M; Artieda J; Obeso JA
Brain; 2006 Jul; 129(Pt 7):1748-57. PubMed ID: 16684788
[TBL] [Abstract][Full Text] [Related]
33. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
[TBL] [Abstract][Full Text] [Related]
34. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
[TBL] [Abstract][Full Text] [Related]
35. Selection of optimal programming contacts based on local field potential recordings from subthalamic nucleus in patients with Parkinson's disease.
Ince NF; Gupte A; Wichmann T; Ashe J; Henry T; Bebler M; Eberly L; Abosch A
Neurosurgery; 2010 Aug; 67(2):390-7. PubMed ID: 20644424
[TBL] [Abstract][Full Text] [Related]
36. Balance between competing spectral states in subthalamic nucleus is linked to motor impairment in Parkinson's disease.
Khawaldeh S; Tinkhauser G; Torrecillos F; He S; Foltynie T; Limousin P; Zrinzo L; Oswal A; Quinn AJ; Vidaurre D; Tan H; Litvak V; Kühn A; Woolrich M; Brown P
Brain; 2022 Mar; 145(1):237-250. PubMed ID: 34264308
[TBL] [Abstract][Full Text] [Related]
37. Gender-related differences in the human subthalamic area: a local field potential study.
Marceglia S; Mrakic-Sposta S; Foffani G; Cogiamanian F; Caputo E; Egidi M; Barbieri S; Priori A
Eur J Neurosci; 2006 Dec; 24(11):3213-22. PubMed ID: 17156382
[TBL] [Abstract][Full Text] [Related]
38. Use of intraoperative local field potential spectral analysis to differentiate basal ganglia structures in Parkinson's disease patients.
Kolb R; Abosch A; Felsen G; Thompson JA
Physiol Rep; 2017 Jun; 5(12):. PubMed ID: 28642341
[TBL] [Abstract][Full Text] [Related]
39. Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.
Lenka A; Jhunjhunwala KR; Stezin A; Manjunath M; Srinivas D; Yadav R; Pal PK
Neurol India; 2018; 66(Supplement):S135-S137. PubMed ID: 29503336
[TBL] [Abstract][Full Text] [Related]
40. Movement-related modulation of neural activity in human basal ganglia and its L-DOPA dependency: recordings from deep brain stimulation electrodes in patients with Parkinson's disease.
Priori A; Foffani G; Pesenti A; Bianchi A; Chiesa V; Baselli G; Caputo E; Tamma F; Rampini P; Egidi M; Locatelli M; Barbieri S; Scarlato G
Neurol Sci; 2002 Sep; 23 Suppl 2():S101-2. PubMed ID: 12548363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
